Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release.
The investment is valued at up to $430 million.
Saama, based in Campbell, Calif., is an AI clinical analytics platform company. Founded in 1997, the company states that biotech companies use Saama’s Life Science Analytics Cloud platform